Medscape (2/7, McNamara, Subscription Publication) reported, “Choosing the best treatment option for post-stroke depression remains more art than science, with little evidence to support one therapeutic approach over another, new research shows.” A review “showed ‘very low certainty of evidence’ when evaluating pharmacologic treatments, noninvasive brain stimulation, psychological strategies, or a combination of these approaches, the investigators report,” although “there was a suggestion that combining antidepressants with other therapies may offer a small edge.” The study results were published online January 28 in the Cochrane Database of Systematic Reviews. (SOURCE: APA Headlines)